• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评价 Peptest 免疫测定法的重要分析参数对其在诊断胃食管反流病中的应用限制。

Evaluation of Important Analytical Parameters of the Peptest Immunoassay that Limit its Use in Diagnosing Gastroesophageal Reflux Disease.

机构信息

Internal Gastroenterology Department.

Department of Bioanalytical Instrumentation, CEITEC Masaryk University.

出版信息

J Clin Gastroenterol. 2019 May/Jun;53(5):355-360. doi: 10.1097/MCG.0000000000001066.

DOI:10.1097/MCG.0000000000001066
PMID:29863588
Abstract

GOAL

To evaluate the analytical parameters of a lateral flow (LF) pepsin immunoassay (Peptest) and assess its suitability in the diagnostics of gastroesophageal reflux disease (GERD).

BACKGROUND

Peptest is a noninvasive assay to analyze pepsin in saliva, intended for use in GERD diagnostics. Although commercialized, fundamental studies on its performance are missing. The assay therefore requires basic analytical parameter evaluation to assess its suitability in clinical practice.

STUDY

Assay reaction's time dependence, reader device repeatability, and individual LF devices and longitudinal pepsin concentration reproducibility in individual subjects was evaluated. Salivary pepsin was analyzed in 32 GERD patients with extraesophageal reflux symptoms and 13 healthy individuals.

RESULTS

The assay's signal increase is not completed at the recommend readout time and continues to increase for another 25 minutes. The relative standard deviation of measurement was good when using the same LF device, ranging from 2.3% to 12.9%, but the reproducibility of 10 different individual LF devices was poor. The random error when analyzing the same saliva sample on 10 LF devices was as high as 36 ng/mL and this value is thus suggested as the positivity cut-off. Pepsin concentration in individual subjects during a 10-day period varied significantly. The sensitivity of the Peptest was 36.8% in the group with acid reflux and 23.1% in the group with weakly acid reflux. The specificity was 61.5%.

CONCLUSIONS

The Peptest assay's sensitivity and specificity is low, the results are highly variable and it should not be used as a near-patient diagnostic method in primary care.

摘要

目的

评估侧向流动(LF)胃蛋白酶免疫测定(Peptest)的分析参数,并评估其在胃食管反流病(GERD)诊断中的适用性。

背景

Peptest 是一种分析唾液中胃蛋白酶的非侵入性检测方法,旨在用于 GERD 诊断。尽管已经商业化,但缺乏对其性能的基础研究。因此,该检测需要进行基本的分析参数评估,以评估其在临床实践中的适用性。

研究

评估了检测反应的时间依赖性、阅读器设备的重复性以及个体 LF 设备和个体受试者中纵向胃蛋白酶浓度的重现性。对 32 例有食管外反流症状的 GERD 患者和 13 例健康个体进行了唾液胃蛋白酶分析。

结果

检测的信号增加在推荐的读数时间内并未完成,并且在另外 25 分钟内继续增加。当使用相同的 LF 设备时,测量的相对标准偏差很好,范围为 2.3%至 12.9%,但 10 个不同个体 LF 设备的重现性很差。在 10 个 LF 设备上分析相同唾液样本时的随机误差高达 36ng/mL,因此建议将该值作为阳性截断值。在 10 天期间,个体受试者的胃蛋白酶浓度变化很大。Peptest 在酸反流组中的灵敏度为 36.8%,在弱酸性反流组中的灵敏度为 23.1%。特异性为 61.5%。

结论

Peptest 检测的灵敏度和特异性较低,结果变化较大,不应用于初级保健中的床边诊断方法。

相似文献

1
Evaluation of Important Analytical Parameters of the Peptest Immunoassay that Limit its Use in Diagnosing Gastroesophageal Reflux Disease.评价 Peptest 免疫测定法的重要分析参数对其在诊断胃食管反流病中的应用限制。
J Clin Gastroenterol. 2019 May/Jun;53(5):355-360. doi: 10.1097/MCG.0000000000001066.
2
Studies of salivary pepsin in patients with gastro-oesophageal reflux disease.胃食管反流病患者唾液胃蛋白酶研究。
Aliment Pharmacol Ther. 2019 May;49(9):1173-1180. doi: 10.1111/apt.15138.
3
Salivary Pepsin Lacks Sensitivity as a Diagnostic Tool to Evaluate Extraesophageal Reflux Disease.唾液胃蛋白酶作为评估食管外反流病的诊断工具缺乏敏感性。
J Pediatr. 2016 Oct;177:53-58. doi: 10.1016/j.jpeds.2016.06.033. Epub 2016 Jul 21.
4
Salivary peptest for laryngopharyngeal reflux and gastroesophageal reflux disease: A systemic review and meta-analysis.唾液肽检测用于咽喉反流和胃食管反流病:系统评价和荟萃分析。
Medicine (Baltimore). 2021 Aug 13;100(32):e26756. doi: 10.1097/MD.0000000000026756.
5
The diagnostic value of pepsin detection in saliva for gastro-esophageal reflux disease: a preliminary study from China.唾液中胃蛋白酶检测对胃食管反流病的诊断价值:一项来自中国的初步研究。
BMC Gastroenterol. 2017 Oct 17;17(1):107. doi: 10.1186/s12876-017-0667-9.
6
Saliva pepsin measurements in the detection of gastroesophageal reflux disease in laryngopharyngeal reflux patients: a cohort study.唾液胃蛋白酶检测在喉咽反流患者胃食管反流病中的诊断价值:一项队列研究。
Eur Arch Otorhinolaryngol. 2023 Aug;280(8):3765-3771. doi: 10.1007/s00405-023-08000-1. Epub 2023 May 4.
7
The clinical application value of salivary pepsin in the diagnosis of gastroesophageal reflux diseases.唾液胃蛋白酶在胃食管反流病诊断中的临床应用价值。
Neurogastroenterol Motil. 2023 Sep;35(9):e14627. doi: 10.1111/nmo.14627. Epub 2023 Jun 18.
8
Measurement of Salivary Pepsin to Detect Gastroesophageal Reflux Disease Is Not Ready for Clinical Application.唾液胃蛋白酶检测用于胃食管反流病的诊断尚不成熟。
Clin Gastroenterol Hepatol. 2019 Feb;17(3):563-565. doi: 10.1016/j.cgh.2018.05.016. Epub 2018 May 18.
9
Threshold level of Peptest in diagnosing gastroesophageal reflux disease with extraesophageal symptoms: Evidence from Vietnam.Peptest在诊断伴有食管外症状的胃食管反流病中的阈值水平:来自越南的证据。
JGH Open. 2023 Nov 20;7(12):916-922. doi: 10.1002/jgh3.13002. eCollection 2023 Dec.
10
Validation in China of a non-invasive salivary pepsin biomarker containing two unique human pepsin monoclonal antibodies to diagnose gastroesophageal reflux disease.在中国验证一种非侵入性唾液胃蛋白酶生物标志物,该标志物含有两种独特的人胃蛋白酶单克隆抗体,用于诊断胃食管反流病。
J Dig Dis. 2019 Jun;20(6):278-287. doi: 10.1111/1751-2980.12783.

引用本文的文献

1
Clinical relevance of salivary pepsin detection in diagnosing gastroesophageal reflux disease subtypes.唾液胃蛋白酶检测在诊断胃食管反流病亚型中的临床相关性。
Gastroenterol Rep (Oxf). 2023 Sep 13;11:goad053. doi: 10.1093/gastro/goad053. eCollection 2023.
2
Laryngopharyngeal Reflux: A State-of-the-Art Algorithm Management for Primary Care Physicians.喉咽反流:基层医疗医生的最新算法管理
J Clin Med. 2020 Nov 10;9(11):3618. doi: 10.3390/jcm9113618.
3
Pepsin in Saliva as a Diagnostic Marker for Gastroesophageal Reflux Disease: A Meta-Analysis.
唾液中的胃蛋白酶原作为胃食管反流病的诊断标志物:一项荟萃分析。
Med Sci Monit. 2018 Dec 31;24:9509-9516. doi: 10.12659/MSM.913978.